These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27502037)

  • 1. Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Bosley ME; Duckworth CG; Porter KR; Kim SH; Kim HG; Chorich LP; Sullivan ME; Choi JH; Cameron RS; Layman LC
    Mol Cell Endocrinol; 2016 Dec; 437():86-96. PubMed ID: 27502037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann Syndrome.
    Poch A; Dougherty MP; Roman RA; Chorich L; Hawkins Z; Kim SH; Kim HG; Layman LC
    Mol Cell Endocrinol; 2024 Aug; 589():112224. PubMed ID: 38593951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Gene Panel Sequencing for Molecular Diagnosis of Kallmann Syndrome and Normosmic Idiopathic Hypogonadotropic Hypogonadism.
    Kim JH; Seo GH; Kim GH; Huh J; Hwang IT; Jang JH; Yoo HW; Choi JH
    Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):538-544. PubMed ID: 30216942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of hypogonadotropic Hypogonadism-Human and mouse genes, inheritance, oligogenicity, and genetic counseling.
    Louden ED; Poch A; Kim HG; Ben-Mahmoud A; Kim SH; Layman LC
    Mol Cell Endocrinol; 2021 Aug; 534():111334. PubMed ID: 34062169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.
    Gach A; Pinkier I; Szarras-Czapnik M; Sakowicz A; Jakubowski L
    Reprod Biol Endocrinol; 2020 Jan; 18(1):8. PubMed ID: 31996231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
    Känsäkoski J; Fagerholm R; Laitinen EM; Vaaralahti K; Hackman P; Pitteloud N; Raivio T; Tommiska J
    Pediatr Res; 2014 May; 75(5):641-4. PubMed ID: 24522099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients.
    Trarbach EB; Baptista MT; Garmes HM; Hackel C
    J Endocrinol; 2005 Dec; 187(3):361-8. PubMed ID: 16423815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gene variants in a cohort of hypogonadotropic hypogonadism: Diagnostic utility of custom NGS panel and WES in unravelling genetic complexity of the disease.
    Gach A; Pinkier I; Sałacińska K; Szarras-Czapnik M; Salachna D; Kucińska A; Rybak-Krzyszkowska M; Sakowicz A
    Mol Cell Endocrinol; 2020 Nov; 517():110968. PubMed ID: 32763379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel mutation in FGFR1 gene in patients with Kallmann syndrome by high throughput sequencing.
    Jin BF; Ji ZY; Su ZY; Mei LB; Huang XJ; Lin SB; Li P; Sha YW
    Syst Biol Reprod Med; 2018 Jun; 64(3):202-206. PubMed ID: 29658329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
    Stamou MI; Georgopoulos NA
    Metabolism; 2018 Sep; 86():124-134. PubMed ID: 29108899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Characteristics of Novel FGFR1 Mutations in Patients with Isolated Gonadotropin-Releasing Hormone Deficiency.
    Choi JH; Oh A; Lee Y; Kim GH; Yoo HW
    Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):457-463. PubMed ID: 32485746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism.
    Turan I; Hutchins BI; Hacihamdioglu B; Kotan LD; Gurbuz F; Ulubay A; Mengen E; Yuksel B; Wray S; Topaloglu AK
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1816-1825. PubMed ID: 28324054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.